Asia Pacific Implantable Medical Devices Market Forecast to 2030 - Regional Analysis - By Nature Type, Product Type, Material Type, Application, and End Users

The Asia Pacific implantable medical devices market is expected to grow from US$20.22 billion in 2022 to US$35.54 billion by 2030. It is estimated to grow at a CAGR of 7.3% from 2022 to 2030.

Rising Cases of Spinal Cord Injury Fuel the Asia Pacific Implantable Medical Devices Market

According to Frontiers' estimates, there were 9 million cases of spinal cord injuries globally in 2019, which is 52.7% more than there were in 1990. The aging demographic coupled with lifestyle-related factors has led to a substantial increase in individuals experiencing spinal issues such as degenerative disc disease and spinal deformities. The demographic shift has created a growing pool of patients seeking effective interventions. Spinal cord stimulation is one of the most preferred techniques in treating chronic back pain, primarily due to the anatomical and functional abilities of the spinal cord nerves to control the sensation of pain. The incidence of spinal cord injuries has rapidly increased over the past decade. Spinal cord stimulators are widely used for managing postoperative pain associated with spinal surgery. Therefore, the high incidence of spinal cord injuries in the geriatric population and adults fuels the demand for implantable neurostimulation devices, boosting the market growth.

Asia Pacific Implantable Medical Devices Market Overview

The Asia Pacific implantable medical devices market is expected to register the highest CAGR during the forecast period. The regional market is expected to grow rapidly in the coming years due to factors such as high CVD prevalence in countries, government initiatives to improve the medical device industry, and robust medical device manufacturing. Additionally, increasing cosmetic surgeries in the region expands the implantable medical devices market growth in Asia Pacific.

Asia Pacific Implantable Medical Devices Market Segmentation

The Asia Pacific implantable medical devices market is segmented into implant type, product type, material type, application, end users, and country.

Based on implant type, the Asia Pacific implantable medical devices market is bifurcated into active implant & passive implant. The passive implant segment held a larger share of the Asia Pacific implantable medical devices market in 2022.

Based on product type, the Asia Pacific implantable medical devices market is bifurcated into diagnostic & treatment. The treatment segment held a larger share of the Asia Pacific implantable medical devices market in 2022.

Based on material type, the Asia Pacific implantable medical devices market is segmented into metallic, ceramic, and polymers. The metallic segment held the largest share of the Asia Pacific implantable medical devices market in 2022.

Based on application, the Asia Pacific implantable medical devices market is segmented into dental implants, orthopedic implants, cardiovascular implants, breast implants, brain implants, and others. The orthopedic implants segment held the largest share of the Asia Pacific implantable medical devices market in 2022.

Based on end users, the Asia Pacific implantable medical devices market is segmented into hospitals, specialty clinics, ASCs, and others. The hospitals segment held the largest share of the Asia Pacific implantable medical devices market in 2022.

Based on country, the Asia Pacific implantable medical devices market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific implantable medical devices market in 2022.

Abbott Laboratories, Boston Scientific Corp, Dentsply Sirona Inc, Johnson & Johnson, Medtronic Plc, Institut Straumann Ag, Smith & Nephew Plc, Biotronik Se & Co Kg, Livanova Plc, And Med-El Elektromedizin Gerate Gesellschaft Mbh are some of the leading companies operating in the Asia Pacific implantable medical devices market.